Q1 2025 revenue was $8.1M, up 34% year-over-year and slightly above guidance; product revenue was $3.5M (up 42% YoY), driven by Monarch 2 projects, while license and services revenue grew 28% YoY due to Qualcomm 5G Taurus license timing.
Gross margin for Q1 2025 was 64.5% (vs. 63.9% in Q1 2024); product gross margin was 31%, impacted by higher module sales and initial CALiP2 launch costs; non-IFRS operating expenses declined to $11M, showing progress toward the target of sub-$11M quarterly cash OPEX.
The design win pipeline reached ~$480M in potential revenue (first three years of sales per project), with $250M in the design win phase and $230M in design-in; 90 new projects were awarded in Q1, expected to generate over $10M in annual revenue at full production, with many contributing to revenue in 2026.
Sequans expects to achieve operating income breakeven in 2026, targeting cash OPEX below $10M/quarter and reducing cash burn to under $5M/quarter by end of 2025; expects to finish 2025 with over $25M in cash and does not foresee the need for an equity raise in 2025 or 2026.
Q2 2025 revenue guidance is $8M–$9M; new product launches (CALiP2, Morag III, CALiP III) and RF transceiver chips are expected to ramp in late 2025–2026, with meaningful revenue from new verticals (defense, public safety) anticipated in late 2026; royalty revenue from a Chinese partner is expected to begin in 2026, and additional strategic licensing deals may close by year-end 2025.